FindTrial
Sign In

A clinical study to assess the potential of myo-d-chiro-inositol in prevention of the development of GDM in pregnant women.

Myo-di chiro Inositol plus Vit D3 versus Vit D3 in the prevention of Gestational Diabetes in Unselected Primis.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014477
Enrollment
1500
Registered
2018-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Myo-d-chiro inositol plus vitamin Vitamin D3 sachets: Twice a daily in water. Control Intervention1: placebo plus Vitamin D3 sachets: Twice a daily in water

Sponsors

Shield Healthcare Pvt Ltd
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Pregnant women 2.Gestation between 11-14 weeks. 2. Willingness to provide the informed consent 3. Willingness and ability to follow the study procedures

Exclusion criteria

Exclusion criteria: 1. Subjects with a known history of diabetetes 2. Pre gestational obesity (BMI over 35) 3. Any condition that in Opinion of the Investigator, does not justify the Subjectsâ?? participation in the study.

Design outcomes

Primary

MeasureTime frame
The prevention of the development of GDM in pregnant womenTimepoint: 11â??14 weeks and 24â??28 weeks of gestation—

Secondary

MeasureTime frame
induction of labor or caesarean section,gestational age at delivery,trauma to mother at delivery Timepoint: End of the study;weight gain / change in BMI,change in glycemic values, necessity of oral hypoglycemics /insulin therapy during pregnancy, preeclampsia Timepoint: 11â??14 weeks and 24â??28 weeks of gestation—

Countries

India

Contacts

Public ContactJestin V Thomas

Divakars Speciality Hospital

drhemadivakar@gmail.com9900154448

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026